IDO1 and colorectal carcinoma: Additionally, in CRC and gastric cancer, TAMs have been shown to upregulate IDO1, which converts tryptophan into kynurenine, a key immunosuppressive metabolite that dampens T-cell activation and promotes immune evasion.